Bioasis Technologies
BIOAF · TSX
$0.0001+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
Key indicators
BIOAF profitability and balance sheet ratios
EPS -$0.0126 in Nov 2022, against -$0.0176 a year earlier.
| Period | EPS |
|---|---|
| Feb 2021 | -$0.0147 |
| May 2021 | -$0.0075 |
| Aug 2021 | -$0.008 |
| Nov 2021 | -$0.0176 |
| Feb 2022 | -$0.0078 |
| May 2022 | -$0.0032 |
| Aug 2022 | -$0.0139 |
| Nov 2022 | -$0.0126 |
Income statement
No financial statements are reported for Bioasis Technologies.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | May 2022 | Aug 2022 | Nov 2022 |
|---|---|---|---|
| Total assets | $1.3M | $2.3M | $1.8M |
| Total liabilities | $3.4M | $4.0M | $4.5M |
| Shareholder equity | −$2.1M | −$1.7M | −$2.7M |
| Cash and short-term investments | $0.8M | $0.6M | $0.2M |
| Total debt | $1.8M | $2.0M | $2.2M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.